跳至主要内容
临床试验/NCT00675077
NCT00675077Unknown1 期

Phase 1 Study to Determine the Efficacy of Using Far Infrared Radiation for Control, Management and Treatment of HD

GAAD Medical Research Institute Inc.2 个研究点 分布在 1 个国家目标入组 5 人开始时间: 2008年5月1日最近更新:
适应症

试验速览

阶段
1 期
发起方
入组人数
5
试验地点
2
主要终点
Treatment of people with HD

研究概览

简要总结

Huntington's disease (HD) is a fatal disease with profound neurological and behavioral features. HD is typically characterized by uncontrollable movements and psychological disturbances.

This study will investigate the use of far infrared radiation for control, management and treatment of HD.

详细描述

Observations from our research studies indicate that, far infrared rays provide energy to the body, improve the autonomic functions of the nervous system, restore the functions of the endocrine system, strengthen the immune system, improve blood circulation and increase the level of oxygen in the cells and promote the regeneration of muscle cells, nerves and brain cells.

It is hereby postulated that irradiation using far infrared, with wavelength between 5 to 20 microns, of the central nervous system, the endocrine system and the whole body could prevent, control, manage or possibly lead to complete rehabilitation of people who have HD.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

性别
All
接受健康志愿者

入选标准

  • People with HD

排除标准

  • 未提供

结局指标

主要结局

Treatment of people with HD

时间窗: 2 years

次要结局

  • Rehabilitation of people with HD(2 Years)

研究者

发起方
GAAD Medical Research Institute Inc.
申办方类型
Other

研究点 (2)

Loading locations...

相似试验